0000950170-25-085215.txt : 20250612 0000950170-25-085215.hdr.sgml : 20250612 20250612113604 ACCESSION NUMBER: 0000950170-25-085215 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250610 FILED AS OF DATE: 20250612 DATE AS OF CHANGE: 20250612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WILLIAMS ROBERT M JR CENTRAL INDEX KEY: 0001239610 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40362 FILM NUMBER: 251042118 MAIL ADDRESS: STREET 1: 212 ELM STREET, SUITE 1 CITY: NEW CANAAN STATE: CT ZIP: 06840 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aveanna Healthcare Holdings, Inc. CENTRAL INDEX KEY: 0001832332 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 844717209 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 400 INTERSTATE NORTH PARKWAY STREET 2: STE 1700 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 770-441-1580 MAIL ADDRESS: STREET 1: 400 INTERSTATE NORTH PARKWAY STREET 2: STE 1700 CITY: ATLANTA STATE: GA ZIP: 30339 4 1 ownership.xml 4 X0508 4 2025-06-10 0001832332 Aveanna Healthcare Holdings, Inc. AVAH 0001239610 WILLIAMS ROBERT M JR C/O J.H. WHITNEY CAPITAL PARTNERS, LLC 212 ELM STREET NEW CANAAN CT 06840 false false true false false Common Stock, $0.01 par value 0 D Common Stock, $0.01 par value 2025-06-10 4 S false 750000 5.2 D 28890756 I By J.H. Whitney VII, L.P. Common Stock, $0.01 par value 15588582 I By PSA Healthcare Investment Holding LLC Common Stock, $0.01 par value 5182086 I By JHW Iliad Holdings LLC Common Stock, $0.01 par value 1443143 I By PSA Iliad Holdings LLC Common Stock, $0.01 par value 543207 I By JHW Iliad Holdings II LLC J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holding LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. /s/ David Zatlukal, Attorney-in-Fact 2025-06-12